Literature DB >> 26880164

DIPNECH: Association Between Histopathology and Clinical Presentation.

Rocco Trisolini1,2, Ilaria Valentini3, Carmine Tinelli4, Marco Ferrari3, Gian Marco Guiducci5, Sergio Nicola Forti Parri5, Giorgia Dalpiaz6, Alessandra Cancellieri7.   

Abstract

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare disorder which can be an incidental finding in imaging tests performed during the investigation of another condition, or is the final diagnosis in patients evaluated for chronic obstructive complaints. To explore the possible association between specific histopathology features and the mode of clinical presentation, we retrieved the clinical, functional, radiological, and pathological data of all 13 patients diagnosed with DIPNECH at our Institution over a 14-year period (2000-2014). As compared to patients with incidental disease (6/13, 46 %), patients with symptomatic disease were younger [mean (SD): 57.7 vs. 68.7 years, p = 0.046], were more likely to have mosaic attenuation (100 vs. 0 %, p = 0.001) and small multiple nodules (100 vs. 17 %, p = 0.005) at CT, and showed a significantly higher number of foci of linear neuroendocrine proliferation [median (IQR): 28 (13-37) vs. 6 (5-13), p = 0.018] and of tumorlets [median (IQR): 10 (8-20) vs. 1 (1-1), p = 0.002] at histology. Incidental disease was found in association with pulmonary adenocarcinoma in five out of six patients (83.3 %). The results of our study provide preliminary evidence that symptomatic patients with DIPNECH represent a specific subset characterized by younger age and a higher burden of foci of neuroendocrine proliferation.

Entities:  

Keywords:  Bronchiolitis; Carcinoid; Computed tomography; Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia; Tumorlets

Mesh:

Year:  2016        PMID: 26880164     DOI: 10.1007/s00408-016-9854-7

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  14 in total

1.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity.

Authors:  Alexander Gorshtein; David J Gross; Dganit Barak; Yulia Strenov; Yael Refaeli; Ilan Shimon; Simona Grozinsky-Glasberg
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

2.  The bronchoconstrictor action of the tetradecapeptide bombesin in the guinea-pig.

Authors:  M Impicciatore; G Bertaccini
Journal:  J Pharm Pharmacol       Date:  1973-11       Impact factor: 3.765

3.  The clinical course of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Authors:  Laurie L Carr; Jonathan H Chung; Rosane Duarte Achcar; Zoran Lesic; Ji Y Rho; Kunihiro Yagihashi; Robert M Tate; Jeffrey J Swigris; Jeffrey A Kern
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

4.  Gastrin-releasing peptide blockade as a broad-spectrum anti-inflammatory therapy for asthma.

Authors:  Shutang Zhou; Erin N Potts; Frank Cuttitta; W Michael Foster; Mary E Sunday
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-20       Impact factor: 11.205

Review 5.  Advances in neuroendocrine lung tumors.

Authors:  W D Travis
Journal:  Ann Oncol       Date:  2010-10       Impact factor: 32.976

Review 6.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview.

Authors:  Adrienne A Nassar; Dawn E Jaroszewski; Richard A Helmers; Thomas V Colby; Bhavesh M Patel; Farouk Mookadam
Journal:  Am J Respir Crit Care Med       Date:  2011-03-25       Impact factor: 21.405

7.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease.

Authors:  Susan J Davies; John R Gosney; David M Hansell; Athol U Wells; Roland M du Bois; Margaret M Burke; Mary N Sheppard; Andrew G Nicholson
Journal:  Thorax       Date:  2006-11-10       Impact factor: 9.139

8.  Gastrin-releasing peptide, immune responses, and lung disease.

Authors:  Simone Degan; Giselle Y Lopez; Katharine Kevill; Mary E Sunday
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

9.  Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors.

Authors:  R R Miller; N L Müller
Journal:  Am J Surg Pathol       Date:  1995-06       Impact factor: 6.394

10.  Contractile effect of bombesin on guinea pig lung in vitro: involvement of gastrin-releasing peptide-preferring receptors.

Authors:  E Lach; E B Haddad; J P Gies
Journal:  Am J Physiol       Date:  1993-01
View more
  2 in total

1.  Coexistence of DIPNECH and carotid body paraganglioma: is it just a coincidence?

Authors:  J Pedro; F M Cunha; V Neto; V Hespanhol; D F Martins; S Guimarães; A Varela; D Carvalho
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-05-13

2.  De-labelling severe asthma diagnosis: the challenge of DIPNECH.

Authors:  Caroline Hurabielle; Camille Taillé; Grégoire Prévot; Maud Russier; Alain Didier; Pierre-Olivier Girodet; Magali Colombat; Julien Mazières; Laurent Guilleminault
Journal:  ERJ Open Res       Date:  2022-02-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.